PepGen Inc. is a biotechnology company focused on developing transformative therapies for severe neuromuscular and neurologic diseases, utilizing its Enhanced Delivery Oligonucleotide platform.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!